Bullfrog AI Holdings Inc. (NASDAQ:BFRG – Get Free Report) was the recipient of a significant increase in short interest during the month of October. As of October 15th, there was short interest totaling 407,400 shares, an increase of 58.1% from the September 30th total of 257,700 shares. Currently, 6.3% of the shares of the company are sold short. Based on an average daily trading volume, of 217,700 shares, the short-interest ratio is currently 1.9 days. Based on an average daily trading volume, of 217,700 shares, the short-interest ratio is currently 1.9 days. Currently, 6.3% of the shares of the company are sold short.
Analyst Ratings Changes
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Bullfrog AI in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Bullfrog AI presently has an average rating of “Sell”.
Read Our Latest Analysis on Bullfrog AI
Bullfrog AI Stock Down 9.4%
Bullfrog AI (NASDAQ:BFRG – Get Free Report) last issued its earnings results on Wednesday, August 13th. The company reported ($0.15) earnings per share (EPS) for the quarter. The business had revenue of $0.03 million during the quarter.
Hedge Funds Weigh In On Bullfrog AI
A hedge fund recently bought a new stake in Bullfrog AI stock. Virtu Financial LLC purchased a new position in shares of Bullfrog AI Holdings Inc. (NASDAQ:BFRG – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 20,504 shares of the company’s stock, valued at approximately $34,000. Virtu Financial LLC owned 0.22% of Bullfrog AI as of its most recent SEC filing. 0.96% of the stock is currently owned by institutional investors and hedge funds.
About Bullfrog AI
Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.
Further Reading
- Five stocks we like better than Bullfrog AI
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- The Best Local Butchers for Thanksgiving [2025 Survey]
- Consumer Staples Stocks, Explained
- $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.
